AFP and hepatocellular carcinoma: The serum-detectable, cleaved, soluble extracellular portion of the transforming receptor tyrosine kinase (sAxl), a member of the tumor-associated macrophage family, was found to have sensitivity 84.6% and specificity 76.3% for the diagnosis of AFP-negative HCC with higher diagnostic performance than that of AFP for early HCC [59].